HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
arrow_back

Go back to trials list

Allogeneic Hematopoietic Progenitor Cell Transplantation From Unrelated Donors


Description

The purpose of this study is to provide an opportunity for patients with malignancies or bone marrow failure states who lack a suitable sibling donor to undergo allogeneic hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries.same

Trial Eligibility

Inclusion Criteria: > 18 years of Age < 70 years ECOG performance status 0, 1 or 2 Left Ventricular Ejection Fraction > 30% Creatinine clearance > 40ml/min Transaminases < 2X normal Total bilirubin < 2X normal HIV seronegativity Weight < 70kg for cord blood transplantation Ability to cover the cost of the transplant, necessary medications, and transportation/housing. Caregiver must be available while outpatient Exclusion Criteria: Greater than one antigen mismatch at HLA-A, B, C or DR plus one allele mismatch at HLA-A, B, C or DR

Study Info

Organization

Scripps Health


Primary Outcome

Bone Marrow and Peripheral Blood Chimerism


Outcome Timeframe 30 days post-transplant

NCTID NCT01364363

Phase Not Applicable

Primary Purpose Treatment

Completion Date July 2015

Interventions

Procedure Allogeneic transplantation

Locations Recruiting

Scripps Green Hospital

United States, California, La Jolla


Interested in joining this trial?

Our dedicated patient navigators are here to guide you through the validation and enrollment process with ease.

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
GSK
Regeneron
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube